Rituximab - PDFSEARCH.IO - Document Search Engine

Rituximab
Results: 190

#	Item
71	Background Information Roche in Rheumatology: Changing the Treatment of Rheumatoid Arthritis Rheumatoid Arthritis: the treatment gap The prevalence of rheumatoid arthritis (RA) varies between 0.3% and 1% worldwide and i Add to Reading List Source URL: www.roche.com Language: English - Date: 2011-05-26 01:00:00 Immunosuppressants Connective tissue diseases Arthritis Autoimmune diseases Rheumatology Tocilizumab Rheumatoid arthritis Rituximab Genentech Health Medicine Anatomy
72	Microsoft Word - PRTX_SCIR.doc Add to Reading List Source URL: scr.zacks.com Language: English - Date: 2013-09-16 11:37:44 Pharmacology Rheumatoid arthritis Etanercept Infliximab TNF inhibitor Disease-modifying antirheumatic drug Adalimumab Leflunomide Rituximab Medicine Immunosuppressants Anatomy
73	Background Information Roche in Rheumatology: Changing the Treatment of Rheumatoid Arthritis Rheumatoid Arthritis: the treatment gap The prevalence of rheumatoid arthritis (RA) varies between 0.3% and 1% worldwide and i Add to Reading List Source URL: www.roche.com Language: English - Date: 2011-05-26 01:00:00 Immunosuppressants Connective tissue diseases Arthritis Autoimmune diseases Rheumatology Tocilizumab Rheumatoid arthritis Rituximab Genentech Health Medicine Anatomy
74	National Cancer Drugs Fund List Ver3.1 Ver3.1 National CDF List Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2015-01-22 16:13:36 Lymphoma Bevacizumab Radiation therapy Adjuvant therapy Mantle cell lymphoma Rituximab Prostate cancer Bendamustine Renal cell carcinoma Medicine Orphan drugs Cancer treatments
75	Available online http://arthritis-research.com/content/8/6/R167 Research article Vol 8 No 6 Open Access Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Biology Connective tissue diseases Immunology Immune system Monoclonal antibodies B-cell activating factor Rituximab BAFF Rheumatoid arthritis Anatomy Health Autoimmune diseases
76	Objective is to derive the over all incidence/ prevalence of PML in the USA JCV/PML Reasons for unknown incidence Not reported Add to Reading List Source URL: patients.aan.com Language: English* - Date: 2009-11-10 12:34:40 Immunology Progressive multifocal leukoencephalopathy Natalizumab Rituximab Efalizumab Hematological malignancy Psoriasis JC virus Medicine Immunosuppressants Health
77	pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2015-01-09 16:28:10 Lymphocytic leukemia Pharmacology B-cell chronic lymphocytic leukemia Orphan drugs Ofatumumab Leukemia Rituximab Mantle cell lymphoma End point of clinical trials Medicine Health Medical statistics
78	considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2014-12-04 16:10:34 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Ofatumumab B-cell chronic lymphocytic leukemia Chlorambucil Fludarabine Leukemia Rituximab Chemistry Medicine Oncology
79	JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area Product Name Add to Reading List Source URL: files.shareholder.com Language: English Orphan drugs Bendamustine Benzimidazoles Organochlorides Rituximab B-cell chronic lymphocytic leukemia Lenalidomide Genmab Mantle cell lymphoma Medicine Oncology Chemistry
80	Velcade-II-72 Summary of opinion Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2014-12-19 07:36:07 Lymphoma Bortezomib Pyrazines Mantle cell lymphoma European Medicines Agency Hematopoietic stem cell transplantation Dexamethasone Multiple myeloma Rituximab Medicine Orphan drugs Amides

UPDATE